Literature DB >> 23439899

Trends in resource utilization for hospitalized children with skin and soft tissue infections.

Michelle A Lopez1, Andrea T Cruz, Marc A Kowalkowski, Jean L Raphael.   

Abstract

OBJECTIVE: To describe trends in national resource utilization for pediatric skin and soft tissue infection (SSTI) hospitalizations.
METHODS: This was a cross-sectional analysis of hospital discharges from 1997 to 2009 within the Healthcare Cost and Utilization Project Kids' Inpatient Database for children with isolated SSTIs. Outcomes examined included patient and hospital characteristics, number of hospitalizations, and resource utilization including length of stay (LOS), hospital charges, and performance of incision and drainage (I&D). Trends in resource utilization were assessed by using linear regression in a merged data set with survey year as the primary independent variable. Multivariate logistic regression was conducted for 2009 data to assess factors associated with increased I&D.
RESULTS: The weighted proportion of SSTI hospitalizations among all hospitalizations doubled (0.46% vs 1.01%) from 1997 to 2009. During the same period, patient demographic trends included a shift to increased hospitalizations in infant and preschool-age groups as well as publicly insured children. Mean LOS decreased from 3.11 to 2.71 days. Increased resource utilization included changes in mean charges from $6722 to $11 534 per hospitalization and a twofold increase in I&D (21% to 44%). Factors associated with I&D include young age, African American race, female gender, publicly or uninsured children, and southern region of the United States.
CONCLUSIONS: SSTI is responsible for an emerging increase in health services utilization. Additional study is warranted to identify interventions that may effectively address this public health burden.

Entities:  

Mesh:

Year:  2013        PMID: 23439899      PMCID: PMC3581839          DOI: 10.1542/peds.2012-0746

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

1.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Dale Everett; Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Edward L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2005-10-14       Impact factor: 9.079

Review 2.  Cellulitis and erysipelas.

Authors:  Andrew Morris
Journal:  Clin Evid       Date:  2006-06

3.  Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital.

Authors:  Kevin Purcell; Jaime Fergie
Journal:  Arch Pediatr Adolesc Med       Date:  2005-10

4.  Three-year surveillance of community-acquired Staphylococcus aureus infections in children.

Authors:  Sheldon L Kaplan; Kristina G Hulten; Blanca E Gonzalez; Wendy A Hammerman; Linda Lamberth; James Versalovic; Edward O Mason
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

5.  Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas.

Authors:  Ana M Avalos Mishaan; Edward O Mason; Gerardo Martinez-Aguilar; Wendy Hammerman; Jennifer J Propst; James R Lupski; Pawel Stankiewicz; Sheldon L Kaplan; Kristina Hulten
Journal:  Pediatr Infect Dis J       Date:  2005-03       Impact factor: 2.129

6.  Methicillin-resistant Staphylococcus aureus in two child care centers.

Authors:  P M Adcock; P Pastor; F Medley; J E Patterson; T V Murphy
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

7.  Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections.

Authors:  John Edelsberg; Ariel Berger; David J Weber; Rajiv Mallick; Andreas Kuznik; Gerry Oster
Journal:  Infect Control Hosp Epidemiol       Date:  2008-02       Impact factor: 3.254

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children's Health Plan.

Authors:  Kevin Purcell; Jaime Fergie; Mary Dale Peterson
Journal:  Pediatr Infect Dis J       Date:  2006-02       Impact factor: 2.129

10.  Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Daniel J Pallin; Daniel J Egan; Andrea J Pelletier; Janice A Espinola; David C Hooper; Carlos A Camargo
Journal:  Ann Emerg Med       Date:  2008-01-28       Impact factor: 5.721

View more
  10 in total

1.  Variation in Antibiotic Selection and Clinical Outcomes in Infants <60 Days Hospitalized With Skin and Soft Tissue Infections.

Authors:  Jessica L Markham; Matthew Hall; Mary Ann Queen; Paul L Aronson; Sowdhamini S Wallace; Dana M Foradori; Gabrielle Hester; Jennifer Nead; Michelle A Lopez; Andrea T Cruz; Russell J McCulloh
Journal:  Hosp Pediatr       Date:  2019-01

2.  Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009.

Authors:  Elia M Pestana Knight; Nicholas K Schiltz; Paul M Bakaki; Siran M Koroukian; Samden D Lhatoo; Kitti Kaiboriboon
Journal:  Epilepsia       Date:  2015-01-29       Impact factor: 5.864

3.  Trends in hospitalizations and resource utilization for pediatric pertussis.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Hosp Pediatr       Date:  2014-09

4.  Outpatient management of moderate cellulitis in children using high-dose oral cephalexin.

Authors:  Evelyne D Trottier; Beatrice Farley St-Amand; Mélanie Vincent; Isabelle Chevalier; Julie Autmizguine; Stéphanie Tremblay; Serge Gouin
Journal:  Paediatr Child Health       Date:  2022-05-03       Impact factor: 2.600

5.  Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-08-20       Impact factor: 3.254

6.  Clinical characteristics and antibiotic utilization in pediatric patients hospitalized with acute bacterial skin and skin structure infection.

Authors:  S Jason Moore; Sean T O'Leary; Brooke Caldwell; Bryan C Knepper; Sean W Pawlowski; William J Burman; Timothy C Jenkins
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

7.  Factors associated with high resource utilization in pediatric skin and soft tissue infection hospitalizations.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Hosp Pediatr       Date:  2013-10

8.  Necrotizing soft tissue infection of both ear lobules occurring concomitantly in a set of twins following non-aseptic ear piercing: a case report.

Authors:  U U Nnadozie; O B Ezeanosike; C C Maduba; D C Obu; U S D Unigwe
Journal:  BMC Pediatr       Date:  2020-02-05       Impact factor: 2.125

9.  Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review.

Authors:  Giulio Rizzetto; Elisa Molinelli; Giulia Radi; Federico Diotallevi; Oscar Cirioni; Lucia Brescini; Andrea Giacometti; Annamaria Offidani; Oriana Simonetti
Journal:  Antibiotics (Basel)       Date:  2022-07-14

10.  Cellulitis in children: a retrospective single centre study from Australia.

Authors:  Elise Salleo; Conor I MacKay; Jeffrey Cannon; Barbara King; Asha C Bowen
Journal:  BMJ Paediatr Open       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.